Clinical trials: ICAS - Intracranial Atherosclerosis

Cerebral Atherosclerosis

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

• Completed
• Age: 40 to 75 years
• Phase 4
• Results posted

The purpose of this study is to obtain additional data on efficacy and safety of Divaza for adjustment of oxidative disorders in patients with cerebral atherosclerosis.

Trial name

NCT03485495

Testing

Divaza

Where

10 sites in Russia

Volunteers

124 people

Sponsor

Materia Medica Holding